SCHEMBL13304697

SCHEMBL13304697

CCC(C)c1cc(CI)n2nccc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 19/20 0.49
CDK9 P50750 19/20 0.49
CDK7 P50613 4/20 0.40
CCNH P51946 4/20 0.40
CDK4 P11802 3/20 0.40
CCND1 P24385 3/20 0.40
CCNK O75909 1/20 0.40
CDK14 O94921 1/20 0.40
CYP1A2 P05177 1/20 0.40
CDK1 P06493 1/20 0.40
CCNA2 P20248 1/20 0.40
CCNC P24863 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CCNA1 P78396 1/20 0.40
CDK3 Q00526 1/20 0.40
CDK6 Q00534 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK17 Q00537 1/20 0.40
CDK18 Q07002 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545195 0.81 CCNT1 (0.52) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL12953173 0.79 PDE10A (0.54) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL21946516 0.77 CCNT1 (0.61) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL14679358 0.77 PDE4A (0.43) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL14670969 0.72 PDE10A (0.40) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL21877672 0.70 CCNT1 (0.74) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL24418622 0.70 CCNT1 (0.51) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL24174775 0.69 CCNT1 (0.86) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL21877813 0.69 CCNT1 (0.86) CCNT1CDK9CDK7CCNHCDK4
SCHEMBL21946501 0.69 CCNT1 (0.86) CCNT1CDK9CDK7CCNHCDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 EP disclosed